1.Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review
Giovanni DI NARDO ; Federica VISCOGLIOSI ; Francesco ESPOSITO ; Vincenzo STANGHELLINI ; Maria Pia VILLA ; Pasquale PARISI ; Alessia MORLANDO ; Girolamo CALÒ ; Roberto DE GIORGIO
Journal of Neurogastroenterology and Motility 2019;25(4):508-514
Pediatric chronic intestinal pseudo-obstruction is a rare disorder characterized by a severe impairment of gastrointestinal motility leading to intestinal obstruction symptoms in the absence of mechanical causes. The diagnosis is usually clinical and diagnostic work is usually aimed to rule out mechanical obstruction and to identify any underlying diseases. Treatment is challenging and requires a multidisciplinary effort. In this manuscript we describe the youngest child successfully treated with the orally administrable, long-acting, reversible anti-cholinesterase drug, pyridostigmine. Like other drugs belonging to cholinesterase inhibitors, pyridostigmine enhances gut motility by increasing acetylcholine availability in the enteric nervous system and neuro-muscular junctions. Based on the direct evidence from the reported case, we reviewed the current literature on the use of pyridostigmine in severe pediatric dysmotility focusing on intestinal pseudo-obstruction. The overall data emerged from the few published studies suggest that pyridostigmine is an effective and usually well tolerated therapeutic options for patients with intestinal pseudo-obstruction. More specifically, the main results obtained by pyridostigmine included marked reduction of abdominal distension, reduced need of parenteral nutrition, and improvement of oral feeding. The present case and review on pyridostigmine pave the way for eagerly awaited future randomized controlled studies testing the efficacy of cholinesterase inhibitors in pediatric severe gut dysmotility.
Acetylcholine
;
Child
;
Cholinesterase Inhibitors
;
Diagnosis
;
Enteric Nervous System
;
Female
;
Gastrointestinal Motility
;
Humans
;
Intestinal Obstruction
;
Intestinal Pseudo-Obstruction
;
Parenteral Nutrition
;
Pyridostigmine Bromide
2.Prevalence of Non-erosive Esophageal Phenotypes in Children: A European Multicenter Study
Elisa BLASI ; Ettore STEFANELLI ; Renato TAMBUCCI ; Silvia SALVATORE ; Paola De ANGELIS ; Paolo QUITADAMO ; Claudia PACCHIAROTTI ; Giovanni Di NARDO ; Fanj CROCCO ; Enrico FELICI ; Valentina GIORGIO ; Nicoletta STAROPOLI ; Simona SESTITO ; Efstratios SALIAKELLIS ; Osvaldo BORRELLI ; Licia PENSABENE
Journal of Neurogastroenterology and Motility 2023;29(2):156-165
Background/Aims:
Since available data on pediatric non-erosive esophageal phenotypes (NEEPs) are scant, we investigated their prevalence and the phenotype-dependent treatment response in these children.
Methods:
Over a 5-year period, children with negative upper endoscopy, who underwent esophageal pH-impedance (off-therapy) for persisting symptoms not responsive to proton pump inhibitor (PPI)-treatment, were recruited. Based on the results of acid reflux index (RI) and symptom association probability (SAP), patients were categorized into: (1) abnormal RI (non-erosive reflux disease [NERD]), (2) normal RI and abnormal SAP (reflux hypersensitivity [RH]), (3) normal RI and normal SAP (functional heartburn [FH]), and (4) normal RI and not-reliable SAP (normal-RI-not otherwise-specified [normal-RI-NOS]). For each subgroup, treatment response was evaluated.
Results:
Out of 2333 children who underwent esophageal pH-impedance, 68 cases, including 18 NERD, 14 RH, 26 FH, and 10 normal-RI-NOS were identified as fulfilling the inclusion criteria and were analyzed. Considering symptoms before endoscopy, chest pain was more reported in NERD than in other cases (6/18 vs 5/50, P = 0.031). At long-term follow-up of 23 patients (8 NERD, 8 FH, 2 RH, and 5 normal-RI-NOS): 17 were on PPIs and 2 combined alginate, 1 (FH) was on benzodiazepine + anticholinergic, 1 (normal-RI-NOS) on citalopram, and 3 had no therapy. A complete symptom-resolution was observed in 5/8 NERD, in 2/8 FH, and in 2/5 normal-RI-NOS.
Conclusions
FH may be the most common pediatric NEEP. At long-term follow-up, there was a trend toward a more frequent complete symptom resolution with PPI-therapy in NERD patients while other groups did not benefit from extended acid-suppressive-treatment.